| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00430-012-0269-7 |
| P698 | PubMed publication ID | 22965172 |
| P50 | author | Thomas Stamminger | Q89549865 |
| P2093 | author name string | Peter Lischka | |
| Bodo Plachter | |||
| Nadine Frankenberg | |||
| Sandra Pepperl-Klindworth | |||
| P2860 | cites work | No strings attached: the ESCRT machinery in viral budding and cytokinesis | Q24655056 |
| Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region | Q24685870 | ||
| RNA-binding of the human cytomegalovirus transactivator protein UL69, mediated by arginine-rich motifs, is not required for nuclear export of unspliced RNA. | Q25255330 | ||
| DRiPs solidify: progress in understanding endogenous MHC class I antigen processing | Q27006750 | ||
| CRM1 is an export receptor for leucine-rich nuclear export signals | Q27860453 | ||
| The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs | Q28131708 | ||
| Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules | Q28248180 | ||
| A novel transferable nuclear export signal mediates CRM1-independent nucleocytoplasmic shuttling of the human cytomegalovirus transactivator protein pUL69 | Q28366352 | ||
| Nuclear export is evolutionarily conserved in CVC paired-like homeobox proteins and influences protein stability, transcriptional activation, and extracellular secretion | Q28507734 | ||
| Identification of a signal for rapid export of proteins from the nucleus | Q29547742 | ||
| CRM1 is responsible for intracellular transport mediated by the nuclear export signal | Q29547861 | ||
| Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm | Q29618907 | ||
| Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA | Q29620175 | ||
| Human cytomegalovirus UL97 Kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis | Q33227757 | ||
| Polo-like kinase 1 as a target for human cytomegalovirus pp65 lower matrix protein | Q33641664 | ||
| Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression | Q33807009 | ||
| Yeast two hybrid analyses reveal novel binary interactions between human cytomegalovirus-encoded virion proteins. | Q33869574 | ||
| hMSH5 is a nucleocytoplasmic shuttling protein whose stability depends on its subcellular localization | Q33922440 | ||
| Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein. | Q33964039 | ||
| Antigen processing by the proteasome | Q34193262 | ||
| Identification of binary interactions between human cytomegalovirus virion proteins | Q34457964 | ||
| Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. | Q34975513 | ||
| Role of ubiquitin in parainfluenza virus 5 particle formation | Q35826872 | ||
| Export of hepatitis B virus RNA on a Rev-like pathway: inhibition by the regenerating liver inhibitory factor IkappaB alpha. | Q35899426 | ||
| Cellular immunotherapy for viral infection after HSC transplantation | Q35998792 | ||
| Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects | Q36402863 | ||
| Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells | Q36403419 | ||
| Characterization of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus | Q36867674 | ||
| Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus | Q36884645 | ||
| CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity | Q36919192 | ||
| CMV-specific T cell therapy | Q36938907 | ||
| Dynamics of T cell memory in human cytomegalovirus infection | Q37095344 | ||
| Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages | Q37110649 | ||
| CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model | Q37111301 | ||
| Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome | Q37568012 | ||
| Natural and adoptive T-cell immunity against herpes family viruses after allogeneic hematopoietic stem cell transplantation | Q37888687 | ||
| Role of Nucleocytoplasmic RNA Transport during the Life Cycle of Retroviruses | Q38025392 | ||
| Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response | Q39427758 | ||
| Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6 | Q39576878 | ||
| Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes | Q39581864 | ||
| Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. | Q39595874 | ||
| Nuclear targeting of the tegument protein pp65 (UL83) of human cytomegalovirus: an unusual bipartite nuclear localization signal functions with other portions of the protein to mediate its efficient nuclear transport | Q39868792 | ||
| The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture | Q39871910 | ||
| CRM1-mediated nuclear export is required for 26 S proteasome-dependent degradation of the TRIP-Br2 proto-oncoprotein | Q40006400 | ||
| Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasion | Q40148627 | ||
| NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation | Q40635405 | ||
| Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus | Q40729264 | ||
| Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage | Q40757254 | ||
| Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes | Q41034377 | ||
| Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells | Q41179572 | ||
| Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules. | Q41722133 | ||
| The UL69 transactivator protein of human cytomegalovirus interacts with DEXD/H-Box RNA helicase UAP56 to promote cytoplasmic accumulation of unspliced RNA. | Q41807684 | ||
| The CRM1 nuclear export protein in normal development and disease. | Q41860863 | ||
| Nuclear export of the human cytomegalovirus tegument protein pp65 requires cyclin-dependent kinase activity and the Crm1 exporter | Q41994064 | ||
| Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses | Q42120952 | ||
| Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation | Q43406230 | ||
| Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals | Q44042248 | ||
| Modification of the major tegument protein pp65 of human cytomegalovirus inhibits virus growth and leads to the enhancement of a protein complex with pUL69 and pUL97 in infected cells | Q45374877 | ||
| Protein delivery by subviral particles of human cytomegalovirus | Q45858395 | ||
| Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection | Q47898614 | ||
| Quantification of antigen specific CD8+ T cells using an ELISPOT assay | Q47999428 | ||
| Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. | Q54290236 | ||
| Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain. | Q54786854 | ||
| Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus | Q56956215 | ||
| Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene product | Q59098221 | ||
| Activation of p38- and CRM1-dependent nuclear export promotes E2F1 degradation during keratinocyte differentiation | Q61719005 | ||
| The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection | Q67506329 | ||
| Generation and application of a monoclonal antibody raised against a recombinant cytomegalovirus-specific polypeptide | Q68495145 | ||
| A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus | Q69349232 | ||
| Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor | Q72059554 | ||
| Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation | Q77331536 | ||
| Proteolysis: from the lysosome to ubiquitin and the proteasome | Q81354981 | ||
| Direct visualization of the dynamics of antigen presentation in human cells infected with cytomegalovirus revealed by antibodies mimicking TCR specificity | Q83817150 | ||
| P433 | issue | 4 | |
| P921 | main subject | Cytomegalovirus | Q6946 |
| P304 | page(s) | 567-579 | |
| P577 | publication date | 2012-09-11 | |
| P1433 | published in | Medical Microbiology and Immunology | Q15760239 |
| P1476 | title | Nucleocytoplasmic shuttling and CRM1-dependent MHC class I peptide presentation of human cytomegalovirus pp65. | |
| P478 | volume | 201 |
| Q39431526 | CRM1 Inhibitors for Antiviral Therapy |
| Q60913862 | Mouse Model of Cytomegalovirus Disease and Immunotherapy in the Immunocompromised Host: Predictions for Medical Translation that Survived the "Test of Time" |
| Q37611838 | Noncanonical expression of a murine cytomegalovirus early protein CD8 T-cell epitope as an immediate early epitope based on transcription from an upstream gene. |
| Q27015069 | Role of human cytomegalovirus tegument proteins in virion assembly |
Search more.